Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Flaps | 38 | 2015 | 927 | 5.920 |
Why?
|
| Free Tissue Flaps | 20 | 2016 | 372 | 2.920 |
Why?
|
| Thigh | 14 | 2014 | 172 | 2.460 |
Why?
|
| Trachea | 9 | 2013 | 259 | 1.870 |
Why?
|
| Pharynx | 7 | 2014 | 153 | 1.570 |
Why?
|
| Pharyngectomy | 6 | 2012 | 44 | 1.490 |
Why?
|
| Esophagus | 9 | 2014 | 553 | 1.380 |
Why?
|
| Laryngeal Neoplasms | 9 | 2015 | 518 | 1.300 |
Why?
|
| Laryngectomy | 8 | 2015 | 242 | 1.280 |
Why?
|
| Tongue Neoplasms | 5 | 2015 | 246 | 0.960 |
Why?
|
| Head and Neck Neoplasms | 15 | 2014 | 3976 | 0.920 |
Why?
|
| Tissue Scaffolds | 3 | 2013 | 135 | 0.920 |
Why?
|
| Neck | 5 | 2011 | 383 | 0.890 |
Why?
|
| Perforator Flap | 2 | 2014 | 93 | 0.850 |
Why?
|
| Gallbladder | 9 | 2001 | 69 | 0.810 |
Why?
|
| Postoperative Complications | 18 | 2015 | 5542 | 0.780 |
Why?
|
| Microsurgery | 8 | 2014 | 244 | 0.760 |
Why?
|
| Carcinoma, Squamous Cell | 10 | 2015 | 5437 | 0.730 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 554 | 0.710 |
Why?
|
| Esophagectomy | 4 | 2014 | 911 | 0.680 |
Why?
|
| Cervicoplasty | 3 | 2009 | 6 | 0.670 |
Why?
|
| Head | 3 | 2011 | 249 | 0.650 |
Why?
|
| Pharyngeal Diseases | 3 | 2007 | 53 | 0.630 |
Why?
|
| Cutaneous Fistula | 3 | 2007 | 46 | 0.630 |
Why?
|
| Recovery of Function | 10 | 2014 | 703 | 0.610 |
Why?
|
| Bone Transplantation | 5 | 2013 | 134 | 0.590 |
Why?
|
| Glossectomy | 4 | 2015 | 40 | 0.590 |
Why?
|
| Ultrasonography, Doppler | 2 | 2016 | 231 | 0.590 |
Why?
|
| Graft Rejection | 6 | 2016 | 834 | 0.590 |
Why?
|
| Jejunum | 4 | 2012 | 216 | 0.580 |
Why?
|
| Deglutition | 6 | 2015 | 171 | 0.560 |
Why?
|
| Forearm | 4 | 2011 | 67 | 0.560 |
Why?
|
| Oral Fistula | 2 | 2005 | 8 | 0.550 |
Why?
|
| Muscle Contraction | 9 | 2001 | 218 | 0.520 |
Why?
|
| Pharyngeal Neoplasms | 2 | 2006 | 133 | 0.520 |
Why?
|
| Aged | 43 | 2016 | 70117 | 0.510 |
Why?
|
| Esophagoplasty | 2 | 2012 | 27 | 0.510 |
Why?
|
| Anastomosis, Surgical | 5 | 2012 | 371 | 0.510 |
Why?
|
| Tissue and Organ Harvesting | 3 | 2011 | 148 | 0.510 |
Why?
|
| Graft Survival | 9 | 2016 | 1062 | 0.500 |
Why?
|
| Middle Aged | 50 | 2016 | 86204 | 0.490 |
Why?
|
| Cholecystokinin | 5 | 1998 | 45 | 0.470 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2014 | 60 | 0.470 |
Why?
|
| Male | 61 | 2016 | 123000 | 0.470 |
Why?
|
| Angiography | 2 | 2012 | 360 | 0.450 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 502 | 0.440 |
Why?
|
| Muscle, Smooth | 6 | 2001 | 236 | 0.430 |
Why?
|
| Tissue Engineering | 4 | 2013 | 269 | 0.430 |
Why?
|
| Prostheses and Implants | 2 | 2016 | 295 | 0.430 |
Why?
|
| Mandible | 2 | 2010 | 188 | 0.400 |
Why?
|
| Adult | 38 | 2016 | 77950 | 0.400 |
Why?
|
| Female | 55 | 2016 | 141928 | 0.400 |
Why?
|
| Reoperation | 8 | 2016 | 1382 | 0.390 |
Why?
|
| Osteoradionecrosis | 2 | 2010 | 123 | 0.390 |
Why?
|
| Acellular Dermis | 1 | 2012 | 103 | 0.390 |
Why?
|
| Speech Disorders | 2 | 2015 | 91 | 0.380 |
Why?
|
| Esophageal Diseases | 1 | 2011 | 69 | 0.380 |
Why?
|
| Epigastric Arteries | 1 | 2010 | 58 | 0.380 |
Why?
|
| Tracheal Neoplasms | 1 | 2010 | 42 | 0.370 |
Why?
|
| Neuroma | 1 | 2010 | 11 | 0.370 |
Why?
|
| Skull Base | 1 | 2011 | 199 | 0.370 |
Why?
|
| Tracheostomy | 3 | 2010 | 243 | 0.370 |
Why?
|
| Rectus Abdominis | 1 | 2010 | 100 | 0.360 |
Why?
|
| Groin | 1 | 2010 | 74 | 0.360 |
Why?
|
| Mouth Floor | 1 | 2009 | 12 | 0.360 |
Why?
|
| Esthetics | 1 | 2010 | 189 | 0.360 |
Why?
|
| Lower Extremity | 1 | 2012 | 299 | 0.340 |
Why?
|
| Pelvic Exenteration | 1 | 2009 | 108 | 0.340 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2009 | 63 | 0.340 |
Why?
|
| Hypopharyngeal Neoplasms | 2 | 2006 | 82 | 0.330 |
Why?
|
| Hemangioma | 1 | 2010 | 154 | 0.320 |
Why?
|
| Length of Stay | 7 | 2012 | 1900 | 0.320 |
Why?
|
| Aged, 80 and over | 18 | 2015 | 29902 | 0.310 |
Why?
|
| Humans | 61 | 2016 | 261506 | 0.310 |
Why?
|
| Prosthesis Implantation | 2 | 2010 | 263 | 0.310 |
Why?
|
| Skull Base Neoplasms | 1 | 2011 | 314 | 0.310 |
Why?
|
| GTP-Binding Proteins | 3 | 1998 | 321 | 0.300 |
Why?
|
| Respiratory Tract Fistula | 1 | 2007 | 33 | 0.300 |
Why?
|
| Regional Blood Flow | 3 | 2016 | 276 | 0.300 |
Why?
|
| Esophageal Neoplasms | 5 | 2011 | 3168 | 0.300 |
Why?
|
| Polycythemia Vera | 1 | 2009 | 238 | 0.290 |
Why?
|
| Glottis | 1 | 2006 | 67 | 0.280 |
Why?
|
| Carcinoma, Adenoid Cystic | 2 | 2008 | 421 | 0.270 |
Why?
|
| Retrospective Studies | 23 | 2016 | 37905 | 0.270 |
Why?
|
| Treatment Outcome | 20 | 2014 | 32848 | 0.250 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2012 | 882 | 0.250 |
Why?
|
| Postoperative Care | 4 | 2012 | 739 | 0.250 |
Why?
|
| Thoracic Wall | 1 | 2006 | 183 | 0.250 |
Why?
|
| Speech | 1 | 2006 | 133 | 0.250 |
Why?
|
| Mouth | 1 | 2005 | 122 | 0.240 |
Why?
|
| Hospital Costs | 1 | 2006 | 228 | 0.240 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2015 | 10035 | 0.240 |
Why?
|
| Skull | 3 | 2014 | 231 | 0.240 |
Why?
|
| Mouth Neoplasms | 1 | 2009 | 713 | 0.240 |
Why?
|
| Diglycerides | 5 | 2001 | 37 | 0.240 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 5 | 1998 | 21 | 0.240 |
Why?
|
| Rats, Inbred Lew | 2 | 2013 | 113 | 0.230 |
Why?
|
| Cholesterol | 3 | 2001 | 658 | 0.230 |
Why?
|
| Wound Healing | 6 | 2012 | 815 | 0.220 |
Why?
|
| Skin Transplantation | 3 | 2012 | 173 | 0.210 |
Why?
|
| Scrotum | 1 | 2002 | 57 | 0.210 |
Why?
|
| Cranial Sutures | 1 | 2001 | 31 | 0.200 |
Why?
|
| Rectal Neoplasms | 1 | 2010 | 1202 | 0.200 |
Why?
|
| Gait | 2 | 2011 | 165 | 0.200 |
Why?
|
| Logistic Models | 3 | 2016 | 3441 | 0.200 |
Why?
|
| Perineum | 1 | 2002 | 107 | 0.200 |
Why?
|
| Transforming Growth Factor beta | 3 | 2001 | 1130 | 0.200 |
Why?
|
| Algorithms | 4 | 2014 | 3890 | 0.200 |
Why?
|
| Facial Nerve | 2 | 2011 | 64 | 0.190 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2001 | 60 | 0.190 |
Why?
|
| Cholelithiasis | 3 | 2001 | 43 | 0.190 |
Why?
|
| Salvage Therapy | 2 | 2015 | 2054 | 0.190 |
Why?
|
| Rats | 4 | 2013 | 6086 | 0.180 |
Why?
|
| Sensitivity and Specificity | 3 | 2016 | 4971 | 0.180 |
Why?
|
| Mastectomy | 1 | 2006 | 1534 | 0.180 |
Why?
|
| Extremities | 1 | 2001 | 303 | 0.170 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2012 | 7551 | 0.170 |
Why?
|
| Signal Transduction | 6 | 1998 | 11965 | 0.170 |
Why?
|
| Adolescent | 11 | 2012 | 31252 | 0.170 |
Why?
|
| Muscle, Skeletal | 4 | 2012 | 1270 | 0.170 |
Why?
|
| Dogs | 2 | 2010 | 1155 | 0.160 |
Why?
|
| Treatment Failure | 3 | 2014 | 1391 | 0.160 |
Why?
|
| Young Adult | 9 | 2015 | 21445 | 0.160 |
Why?
|
| Speech Intelligibility | 3 | 2015 | 40 | 0.160 |
Why?
|
| Cohort Studies | 6 | 2016 | 9244 | 0.150 |
Why?
|
| Polytetrafluoroethylene | 2 | 2010 | 113 | 0.150 |
Why?
|
| Deglutition Disorders | 2 | 2015 | 447 | 0.150 |
Why?
|
| Tongue | 2 | 2008 | 77 | 0.150 |
Why?
|
| Vagina | 1 | 2009 | 317 | 0.150 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 7222 | 0.150 |
Why?
|
| Membrane Lipids | 1 | 1996 | 48 | 0.140 |
Why?
|
| Chondrocytes | 2 | 2013 | 107 | 0.140 |
Why?
|
| Models, Animal | 2 | 2010 | 664 | 0.140 |
Why?
|
| Calmodulin | 5 | 1998 | 241 | 0.140 |
Why?
|
| Animals | 16 | 2013 | 59536 | 0.130 |
Why?
|
| Follow-Up Studies | 9 | 2015 | 14889 | 0.130 |
Why?
|
| Constriction, Pathologic | 2 | 2007 | 310 | 0.130 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 1323 | 0.130 |
Why?
|
| Orthognathic Surgical Procedures | 1 | 2014 | 21 | 0.120 |
Why?
|
| Prospective Studies | 5 | 2013 | 12873 | 0.120 |
Why?
|
| Fibula | 2 | 2012 | 146 | 0.120 |
Why?
|
| Intracellular Membranes | 1 | 1994 | 108 | 0.120 |
Why?
|
| Rats, Inbred BN | 1 | 2013 | 34 | 0.120 |
Why?
|
| Microvessels | 1 | 2015 | 135 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 4298 | 0.120 |
Why?
|
| Abdominal Muscles | 1 | 2014 | 68 | 0.120 |
Why?
|
| Fat Necrosis | 1 | 2014 | 63 | 0.120 |
Why?
|
| Foreign-Body Reaction | 1 | 2013 | 27 | 0.120 |
Why?
|
| Dermatofibrosarcoma | 2 | 2012 | 72 | 0.110 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 4 | 1998 | 14 | 0.110 |
Why?
|
| Quality of Life | 3 | 2010 | 4532 | 0.110 |
Why?
|
| Skull Neoplasms | 1 | 2012 | 67 | 0.110 |
Why?
|
| Mandibular Reconstruction | 1 | 2013 | 39 | 0.110 |
Why?
|
| Facial Nerve Injuries | 1 | 2011 | 13 | 0.100 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2011 | 20 | 0.100 |
Why?
|
| Sincalide | 5 | 2001 | 37 | 0.100 |
Why?
|
| Sarcoma | 3 | 2012 | 1725 | 0.100 |
Why?
|
| Silk | 1 | 2011 | 17 | 0.100 |
Why?
|
| Fibroins | 1 | 2011 | 20 | 0.100 |
Why?
|
| Temporal Bone | 1 | 2012 | 102 | 0.100 |
Why?
|
| Neoplasms | 3 | 2014 | 15193 | 0.100 |
Why?
|
| Respiratory Mucosa | 1 | 2012 | 206 | 0.100 |
Why?
|
| Nerve Regeneration | 1 | 2011 | 105 | 0.100 |
Why?
|
| Bioprosthesis | 1 | 2012 | 167 | 0.100 |
Why?
|
| Chitosan | 1 | 2011 | 79 | 0.100 |
Why?
|
| Cartilage | 1 | 2011 | 128 | 0.090 |
Why?
|
| Fascia | 1 | 2010 | 68 | 0.090 |
Why?
|
| Mandibular Diseases | 1 | 2010 | 45 | 0.090 |
Why?
|
| Thyroid Neoplasms | 3 | 2006 | 1866 | 0.090 |
Why?
|
| Scalp | 1 | 2012 | 156 | 0.090 |
Why?
|
| Polypropylenes | 1 | 2010 | 25 | 0.090 |
Why?
|
| Facial Paralysis | 1 | 2010 | 60 | 0.090 |
Why?
|
| Polyesters | 1 | 2010 | 53 | 0.090 |
Why?
|
| Forehead | 1 | 2010 | 27 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 399 | 0.090 |
Why?
|
| Linear Models | 1 | 2013 | 1085 | 0.090 |
Why?
|
| Absorbable Implants | 1 | 2010 | 65 | 0.090 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 3 | 2001 | 38 | 0.090 |
Why?
|
| Facial Neoplasms | 1 | 2010 | 84 | 0.090 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 655 | 0.080 |
Why?
|
| Morbidity | 1 | 2010 | 397 | 0.080 |
Why?
|
| Bone Neoplasms | 2 | 2012 | 2576 | 0.080 |
Why?
|
| Face | 1 | 2010 | 273 | 0.080 |
Why?
|
| False Positive Reactions | 1 | 2009 | 355 | 0.080 |
Why?
|
| Leiomyosarcoma | 1 | 2010 | 223 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 2 | 2006 | 3981 | 0.080 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2009 | 106 | 0.080 |
Why?
|
| Cats | 3 | 1998 | 166 | 0.080 |
Why?
|
| Speech, Alaryngeal | 1 | 2007 | 24 | 0.080 |
Why?
|
| Child | 5 | 2011 | 29154 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 622 | 0.080 |
Why?
|
| Transplantation, Homologous | 1 | 2013 | 2843 | 0.070 |
Why?
|
| In Vitro Techniques | 4 | 2001 | 1618 | 0.070 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 1581 | 0.070 |
Why?
|
| Macrophages | 1 | 2013 | 1304 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 15694 | 0.070 |
Why?
|
| Prosthesis Design | 1 | 2010 | 749 | 0.070 |
Why?
|
| Preoperative Care | 2 | 2012 | 1529 | 0.070 |
Why?
|
| Granular Cell Tumor | 1 | 2006 | 22 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2014 | 3890 | 0.070 |
Why?
|
| Vascular Diseases | 1 | 2009 | 246 | 0.070 |
Why?
|
| Microradiography | 1 | 2006 | 5 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2013 | 1818 | 0.070 |
Why?
|
| Skin Neoplasms | 3 | 2012 | 4654 | 0.070 |
Why?
|
| Mammaplasty | 1 | 2014 | 780 | 0.070 |
Why?
|
| Ventilators, Mechanical | 1 | 2006 | 50 | 0.070 |
Why?
|
| Fasciotomy | 1 | 2006 | 43 | 0.070 |
Why?
|
| Cell Membrane | 3 | 2001 | 850 | 0.070 |
Why?
|
| Oroantral Fistula | 1 | 2005 | 3 | 0.070 |
Why?
|
| Neurilemmoma | 1 | 2006 | 127 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2010 | 769 | 0.070 |
Why?
|
| Larynx, Artificial | 1 | 2005 | 43 | 0.070 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 1360 | 0.070 |
Why?
|
| Cicatrix | 1 | 2007 | 208 | 0.070 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2010 | 2231 | 0.070 |
Why?
|
| Benzimidazoles | 3 | 1998 | 428 | 0.060 |
Why?
|
| Neurologic Examination | 1 | 2005 | 245 | 0.060 |
Why?
|
| Bone Regeneration | 2 | 2001 | 32 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2010 | 2292 | 0.060 |
Why?
|
| Protein Kinase C | 3 | 1997 | 396 | 0.060 |
Why?
|
| Neck Dissection | 1 | 2005 | 290 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2012 | 5637 | 0.060 |
Why?
|
| Isoquinolines | 2 | 1994 | 116 | 0.060 |
Why?
|
| Combined Modality Therapy | 3 | 2015 | 8865 | 0.060 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2006 | 261 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2006 | 498 | 0.050 |
Why?
|
| Fournier Gangrene | 1 | 2002 | 5 | 0.050 |
Why?
|
| Comorbidity | 1 | 2008 | 2352 | 0.050 |
Why?
|
| Thrombosis | 1 | 2009 | 781 | 0.050 |
Why?
|
| Risk Factors | 4 | 2015 | 17523 | 0.050 |
Why?
|
| Virulence Factors, Bordetella | 2 | 1998 | 41 | 0.050 |
Why?
|
| Pertussis Toxin | 2 | 1998 | 57 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2006 | 548 | 0.050 |
Why?
|
| Fibrosis | 1 | 2005 | 793 | 0.050 |
Why?
|
| Gallbladder Emptying | 1 | 2001 | 4 | 0.050 |
Why?
|
| Tail | 1 | 2001 | 28 | 0.050 |
Why?
|
| Debridement | 1 | 2002 | 123 | 0.050 |
Why?
|
| Calcium | 3 | 1998 | 1537 | 0.050 |
Why?
|
| Forelimb | 1 | 2001 | 25 | 0.050 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2002 | 129 | 0.050 |
Why?
|
| Joints | 1 | 2001 | 47 | 0.050 |
Why?
|
| Histiocytoma, Malignant Fibrous | 2 | 2012 | 51 | 0.050 |
Why?
|
| Pressure Ulcer | 1 | 2002 | 106 | 0.050 |
Why?
|
| Videotape Recording | 1 | 2001 | 74 | 0.050 |
Why?
|
| Gallbladder Diseases | 1 | 2001 | 43 | 0.050 |
Why?
|
| Hindlimb | 1 | 2001 | 105 | 0.050 |
Why?
|
| Parietal Bone | 1 | 2000 | 18 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2010 | 6100 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2001 | 241 | 0.050 |
Why?
|
| Culture Media | 1 | 2001 | 319 | 0.050 |
Why?
|
| Incidence | 1 | 2011 | 5673 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 3869 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 4844 | 0.050 |
Why?
|
| Time Factors | 2 | 2012 | 12926 | 0.050 |
Why?
|
| Sciuridae | 2 | 1997 | 8 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2001 | 209 | 0.040 |
Why?
|
| Aluminum Compounds | 2 | 1998 | 17 | 0.040 |
Why?
|
| Fluorides | 2 | 1998 | 25 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2012 | 9180 | 0.040 |
Why?
|
| Stents | 1 | 2006 | 1096 | 0.040 |
Why?
|
| Phospholipase C beta | 1 | 1998 | 11 | 0.040 |
Why?
|
| Egtazic Acid | 1 | 1998 | 54 | 0.040 |
Why?
|
| Potassium Chloride | 1 | 1998 | 55 | 0.040 |
Why?
|
| Type C Phospholipases | 1 | 1998 | 53 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2000 | 271 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 6009 | 0.040 |
Why?
|
| Walking | 1 | 2001 | 277 | 0.040 |
Why?
|
| Hospitalization | 1 | 2007 | 2083 | 0.040 |
Why?
|
| Neoplasms, Second Primary | 1 | 2005 | 1350 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2004 | 2203 | 0.040 |
Why?
|
| Cholesterol, Dietary | 1 | 1996 | 54 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2010 | 6869 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 13658 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2001 | 2063 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1998 | 614 | 0.030 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2009 | 356 | 0.030 |
Why?
|
| Guinea Pigs | 3 | 2001 | 241 | 0.030 |
Why?
|
| Progesterone | 1 | 1998 | 513 | 0.030 |
Why?
|
| Palliative Care | 1 | 2006 | 2037 | 0.030 |
Why?
|
| Receptors, Muscarinic | 1 | 1995 | 69 | 0.030 |
Why?
|
| Drug Carriers | 1 | 1996 | 327 | 0.030 |
Why?
|
| Texas | 1 | 2006 | 6311 | 0.030 |
Why?
|
| Piperazines | 2 | 1994 | 2101 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 4320 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 1993 | 13 | 0.030 |
Why?
|
| Strontium | 1 | 1993 | 6 | 0.030 |
Why?
|
| Liposomes | 1 | 1996 | 684 | 0.030 |
Why?
|
| Carcinoma | 1 | 2006 | 2578 | 0.030 |
Why?
|
| Inositol | 1 | 1993 | 27 | 0.030 |
Why?
|
| Gastrostomy | 1 | 2015 | 180 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 1993 | 68 | 0.030 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 1993 | 72 | 0.030 |
Why?
|
| Myosins | 1 | 1993 | 96 | 0.030 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 1994 | 66 | 0.030 |
Why?
|
| Palate, Hard | 1 | 2013 | 12 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 202 | 0.030 |
Why?
|
| Manometry | 1 | 2012 | 74 | 0.030 |
Why?
|
| Maxilla | 1 | 2013 | 84 | 0.030 |
Why?
|
| Pressure | 1 | 2012 | 215 | 0.030 |
Why?
|
| Gastrointestinal Motility | 1 | 2012 | 92 | 0.030 |
Why?
|
| Hemipelvectomy | 1 | 2012 | 40 | 0.030 |
Why?
|
| Mobility Limitation | 1 | 2011 | 31 | 0.030 |
Why?
|
| Contracture | 1 | 2011 | 32 | 0.030 |
Why?
|
| Orbit | 1 | 2013 | 205 | 0.030 |
Why?
|
| Abdominal Wall | 1 | 2014 | 184 | 0.020 |
Why?
|
| Chondrogenesis | 1 | 2011 | 67 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 220 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12221 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 14289 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2011 | 144 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 1994 | 1764 | 0.020 |
Why?
|
| Contraindications | 1 | 2010 | 150 | 0.020 |
Why?
|
| Rabbits | 1 | 2011 | 957 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2010 | 319 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 450 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2015 | 929 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 4938 | 0.020 |
Why?
|
| United States | 1 | 2004 | 15433 | 0.020 |
Why?
|
| Breast | 1 | 2014 | 1344 | 0.020 |
Why?
|
| Mice | 2 | 2011 | 34495 | 0.020 |
Why?
|
| Phosphorylation | 1 | 1993 | 4804 | 0.020 |
Why?
|
| Models, Biological | 1 | 1993 | 3254 | 0.020 |
Why?
|
| Sulfonamides | 1 | 1993 | 1823 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2001 | 2450 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2011 | 4307 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2010 | 3842 | 0.010 |
Why?
|
| Gene Expression | 2 | 2001 | 3570 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 1904 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 2001 | 26 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2001 | 28 | 0.010 |
Why?
|
| Receptors, Cholecystokinin | 1 | 2001 | 29 | 0.010 |
Why?
|
| Colic | 1 | 2001 | 14 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2001 | 116 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2011 | 4078 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2001 | 371 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2001 | 842 | 0.010 |
Why?
|
| Craniotomy | 1 | 2000 | 304 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 7226 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2011 | 4975 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2000 | 370 | 0.010 |
Why?
|
| Benzophenanthridines | 1 | 1997 | 8 | 0.010 |
Why?
|
| Phenanthridines | 1 | 1997 | 10 | 0.010 |
Why?
|
| Alkaloids | 1 | 1997 | 75 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 21713 | 0.010 |
Why?
|
| Biological Transport | 1 | 1997 | 597 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2001 | 1819 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1995 | 96 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 16273 | 0.010 |
Why?
|
| Reference Values | 1 | 1997 | 1099 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2001 | 1863 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 7548 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 1879 | 0.010 |
Why?
|